Unmasking of mixed connective tissue disease by adjuvant IFN alpha therapy for melanoma
Authors:
- 23 February 2006
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 45 (8) , 984-985
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis CDiabetic Medicine, 2001
- Retinopathy associated with high-dose interferon alfa-2b therapyAmerican Journal of Ophthalmology, 2001
- Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and ToxicitiesThe Oncologist, 2001
- Polymyositis occurring during α-interferon treatment for malignant melanoma: a case report and review of the literatureRheumatology International, 1999
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Antiphospholipid syndrome associated with immunotherapy for patients with melanomaCancer, 1994
- Clinical Toxicity of the InterferonsDrug Safety, 1994
- Bullous Eruption with Circulating Pemphigus-Like Antibodies following Interferon-Alpha TherapyDermatology, 1993
- Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides.BMJ, 1989